Provided by Tiger Fintech (Singapore) Pte. Ltd.

BioSig Technologies, Inc.

0.6590
-0.0250-3.65%
Post-market: 0.66500.0060+0.91%19:48 EDT
Volume:63.94K
Turnover:41.71K
Market Cap:11.36M
PE:-0.51
High:0.6870
Open:0.6870
Low:0.6200
Close:0.6840
Loading ...

Company Profile

Company Name:
BioSig Technologies, Inc.
Exchange:
NASDAQ
Establishment Date:
2009
Employees:
4
Office Location:
55 Greens Farms Road,1st Floor,Westport,Connecticut,United States
Zip Code:
06880
Fax:
203 429 5044
Introduction:
BioSig Technologies, Inc., together with its subsidiaries, a medical device company, commercializes advanced digital signal processing technology platform for the treatment of cardiovascular arrhythmias. The company offers PURE EP system, a signal processing platform that combines hardware and software to address known challenges associated to signal acquisition that enables electrophysiologists to see signals and analyze in real-time, as well as is designed to address long-standing limitations that slow and disrupt cardiac catheter ablation procedures. It also focuses on enhancing intracardiac signal acquisition and diagnostic information for catheter ablation procedures for arrhythmias. The company has a research agreement with University of Minnesota to develop novel therapies to treat sympathetic nervous system diseases; and a strategic collaboration with the Mayo Foundation for Medical Education and Research to develop an AI-and machine learning software solution for PURE EP systems. BioSig Technologies, Inc. was incorporated in 2009 and is headquartered in Westport, Connecticut.

Directors

Name
Position
Kenneth L. Londoner
Chief Executive Officer, Chairman, and Director
David Weild IV
Director
Donald E. Foley
Director
Frederick D. Hrkac
Director
James J. Barry
Director
James L. Klein
Director
Patrick J. Gallagher
Director

Shareholders

Name
Position
Kenneth L. Londoner
Chief Executive Officer, Chairman, and Director
John Sieckhaus
Chief Operating Officer
Steve Chaussy
Chief Financial Officer
Michael Graydon Fleming, Jr.
Chief Commercial Officer
Zachary Koch
Clinical Director